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Introduction: Antibiotic resistance has become a serious global concern, and the discovery of novel antimicrobial
herbal constituents may provide valuable solutions to overcome this problem. It is important to identify new
sources of natural antioxidants and antimicrobials. The present study describes for the ﬁrst time the antioxidant,
and antibacterial activities of various fractions of Ononis pubescens L., a traditional Palestinian medicinal plant.
Methods: Antimicrobial activity was tested against selected strains from American Type Culture Collection
(ATCC) and clinical isolates including Shigella sonnie, Staphylococcus aureus, Entrococuss feacium, Escherichia coli,
Pseudomonas aeruginosa, Methicillin Resistant Staphylococcus aureus (MRSA), Candida albicans and
Epidermatophyto ﬂacosum using minimum inhibitory concentration (MIC) assay, while antioxidant activity was
analyzed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging method.
Results: A mixture of phytochemicals was found in all of the studied fractions of O. pubescens, which also showed
remarkable potential with antioxidant and antimicrobial activities.
Conclusion: The current study provides initial data that justify the use and importance of Ononis species in
Palestinian folkloric medicine. Our results showed that Ononis pubescens n-hexane fraction has powerful anti-
bacterial bioactivity against Staphylococcus aureus, as well as the acetone, n-hexane and methanol fractions
which showed excellent potential against Epidermatophyto ﬂacosum fungi, while the acetone fraction showed the
highest antioxidant activity among other fractions. Further investigations are needed to identify and characterize
these constituents.
1. Introduction
Humans have used natural products like plants, microorganisms,
animals, and marine organisms as medicines to treat various diseases,
even prior to the invention of writing. According to fossil records, the
human utilization of plants for treatment of diseases may be traced back
to 60,000 years [1,2].
Knowledge about natural products and their beneﬁts were found the
hard way, by seeking food from the edible plants and materials which
led to various reactions such as diarrhea, vomiting, or other toxic re-
actions and even death. After, the discovery of ﬁre and technological
breakthroughs, the possibility of developing drugs emerged [3]. Plants
are rich sources of many bioactive secondary metabolites that have the
potential to treat diﬀerent aﬄictions, for example, alkaloids, cou-
marins, ﬂavonoids, polyphenols, unsaturated lactones, thiosides, sapo-
nins, cyanosides and essential oils [4,5]. In recent years, phytochemical
secondary metabolites have been extensively investigated as a source of
therapeutic agents. Thus, it is anticipated that phytochemicals with
potential biological properties such as the antibacterial activity will be
used for the treatment of various diseases including bacterial infections
[6,7]. Antibiotic resistance has become a serious global concern, and
the discovery of novel antimicrobial herbal constituents may provide
valuable solutions to overcome the problem [8,9]. New resistance
mechanisms are emerging and spreading globally, threatening the
ability to treat common infectious diseases, resulting in prolonged ill-
ness, disability, and death [10,11].
An imbalance between free radicals and antioxidant systems can
cause oxidative stress in the human body which may result in several
chronic and fatal diseases such as Parkinson's, cardiovascular disease,
Alzheimer's, and cancer. In response, humans produce antioxidant
compounds and enzymes which neutralize these free radicals, but due
to the decreasing levels of these naturally occurring compounds as a
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result of environmental factors and other reasons, this may cause an
increase in oxidative stress which can lead to cell damage and death.
Supplementation containing antioxidants is required at this stage, to
prevent the damage which are caused by these free radicals from nat-
ural or synthetic sources. The investigation of pharmacological active
and safe antioxidants are crucial. The DPPH assay is a simple and ef-
ﬁcient method which based on the measurement of the scavenging
ability of antioxidants towards the stable radical DPPH molecule
[12–14]. Therefore, there is a pressing need for searching of new an-
timicrobial and antioxidant medications with diverse mechanisms of
action.
There are various species among the genus Ononis (Leguminosae
family), which have been shown to have diﬀerent pharmacological
actions such as; antihypertensive [15], antioxidant [16], antibacterial
[17], antifungal [18], analgesic [19], anticancer activities [5,20].
In Palestine, there are ﬁfteen widespread species of the genus Ononis
- O.alopecuroides, O. biﬂora, O. hirta, O. mitissima, O. mollis, O. natrix, O.
ornithopodioides, O. phyllocephala, O. pusilla, O. serrata, O. sicula, O.
spinosa, O. variegate, O. viscosa and O. pubescens [21] Ononis pubescens L.
(O. pubescens) is also known as Downy Rest Harrow, and is an annual
herbaceous plant growing wildly in the Mediterranean regions espe-
cially in Palestine and distributed in the woodlands, shrublands, and
semi-steppe shrublands. The leaves are simple, lanceolate, entire mar-
gined, and pointed apex. They are also trifoliate in the lower part of the
stems, but unifoliada in the high part and covered with yellow, multi-
cellular, glandular, and sticky hairs [21,22].
The O. pubescens aerial parts contain alkyl-isocoumarins, alkylben-
zoic acid and alkylresorcinols derivatives [23]. Recently, increased the
interest rate of alkylresorcinols due to their biological activity, having
been described as inhibitors of glycerol-3 phosphate dehydrogenase and
as the molecules that mediate DNA strand scission [24,25].
The present investigation was intended to screen and to evaluate the
antioxidant and antimicrobial eﬀects of the aqueous, methanol, acetone
and n-hexane fractions of O. pubescens. This plant was chosen because it
has been used traditionally from the ancient times as medicines and
food for cattle in Palestine [26,27].
To the best of our knowledge, there are no previous studies in the
literature about the antimicrobial and antioxidant properties of this
traditional plant making this study the ﬁrst one.
2. Material and methods
2.1. Instrumentation
Shaker incubator apparatus (Memmert shaking incubator,
Germany), Rotavap (Heidolph OB2000-VV2000, Germany), grinder
(Moulinex 1, China), balance (Rad wag, AS 220/c/2, Poland), freeze-
dryer (Mill rock technology-BT85, China), sterile syringe ﬁlter (0.45 μm
25 mm) hydrophobic (PTFE, China), stir-mixer (Tuttnauer,
Jerusalem),weighing scale (Adam Equipments, USA) Incubator with
Co2 (Tuttnauer, Israel), and multichannel micro-pipet (Eppendorf,
Germany)
2.2. Chemicals and reagents
Methanol, NaOH, n-hexane and acetone were purchased from Loba
Chemie, India and Millon’s reagent, Benedict’s reagent and Ninhydrin
solution were obtained from Alfa Agar, England. In addition, Molish’s
reagent, H2SO4 and iodine solution were purchased from Alfa-Aesar,
England. Chloroform and HCl were obtained from Sigma-Aldrich,
Germany. Moreover, magnesium ribbon, acetic acid, FeCl3 and DMSO
(Dimethyl sulfoxide) were obtained from Riedeldehan, Germany. In
addition, the nutrient broth was purchased from Himedia, India. While,
BBL Mueller Hinton II broth, Difco Sabouraud Dextrose Agar, and Bacto
tryptic soy broth were purchased from Dickinson and company Sparks,
USA as well as McConkey agar was obtained from Himedia
Laboratories, India.
2.3. Plant material
The entire O. pubescens plant (roots, stems, leaves, and ﬂowers) was
collected in April 2016 from Bethlehem region of the West Bank/
Palestine. Taxonomical identiﬁcation was performed at the Department
of pharmacy in Pharmacognosy and Herbal Products Laboratory, An-
Najah National University, and the voucher specimen code was Pharm-
PCT-1680.
Once dried at room temperature (after two weeks), the plant ma-
terial was ground and stored in cool dry conditions in the absence of
light.
2.4. Preparation of plant four fractions
The dried powder of O. pubescens was fractionated sequentially by
adding solvents of increasing polarity: hexane (non-polar solvent),
acetone (polar aprotic solvent), methanol (polar protic solvent) and
water (polar protic solvent). About 25 g of the grounded entire plant
was soaked in 500 ml of four diﬀerent solvents (water, methanol,
acetone, n-hexane) separately and placed each one in a shaker device at
100 rounds per minute for 72 h at room temperature, and then stored in
the refrigerator for 4 days. After that, each organic fraction was ﬁltered
and concentrated under vacuum on a rotator evaporator. While aqu-
eous fraction was dried using freeze dryer. Finally, all crude fractions
were stored at 4 °C in the refrigerator for further use [28].
2.5. Phytoconstituents screening
Qualitative phytoconstituents screening for primary and secondary
plant metabolites such as alkaloids, carbohydrates, cardiac glycosides,
ﬂavonoids, protein, monosaccharide, reducing sugar, starch, phenols,
saponins, steroids, terpenoids, and tannins were carried out according
to the standard qualitative analysis of phytogenic compounds as de-
scribed by Trease and Evans, 1983 [29] and Harborne, 1998 [30].
2.6. Microbial isolates
The examined bacterial and fungal isolates were obtained from
American Type Culture Collection. The selected species of micro-
organisms are frequently isolated at clinical settings in our region and
some possess multidrug resistance. The isolates included three Gram-
positive strains: Staphylococcus aureus (ATCC 25923), Staphylococcus
aureus (MRSA), and Enterococcus faecium (ATCC 700221) and three
Gram-negative strains: Escherichia coli (ATCC 25922), Pseudomonas
aeruginosa (ATCC 27853), and Shigella sonnie (ATCC 25931).
Meanwhile, the fungal isolates included Candida albicans (ATCC 90028)
and Epidermatophyto ﬂacosum (ATCC 10231).
2.7. Antimicrobial test
Diﬀerent fractions were screened for antimicrobial activity by using
the well diﬀusion method. Bacterial suspension was prepared by
picking some colony of overnight agar culture of the test organism, and
adding it to a test tube containing 5 ml of nutrient broth, then the
turbidity was compared with that of McFarland nephelometer tube No.
0.5 (1.5*108 cfu/ml); then it was diluted by taking 1000 μl of suspen-
sion and it was added to 2 ml of nutrient broth (0.5*108 cfu/ml). The
MIC is the lowest concentration of an antimicrobial that inhibits the
growth of a microorganism after 18–24 h. Each fraction was subjected
to serial broth dilution technique to determine their minimum in-
hibitory concentration for all tested microorganisms.
2.7.1. Determination of MIC
Microbroth dilution method was used to determine antibacterial
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activities of plant fractions. Into each well of micro- titration plate,
100 μl of Mueller-Hinton broth was placed. A volume of 100 μl of plant
fraction (50 mg/ml) was pippeted into the ﬁrst well and mixed using
the micropipette. This was followed by transferring 100 μl from the
well to the next well. The processes of dilution are repeated up to well
number 11 (negative control of bacterial growth) from which 100 μl
was discharged after mixing. Well number 12 was free from a plant
fraction and was considered the positive control of bacterial growth.
Each examined bacterial strain suspension (e.g. Staphylococcus aureus,
Escherichia coli etc.) was inoculated with 1 μl of a bacterial suspension
(from 5 × 107 CFU/ml bacterial suspension) into all wells except well
number 11 (negative control). In well number 12 (positive control of
bacterial growth), the inoculated bacteria must grow because it's just a
broth and if the bacteria did not grow this means there was a problem
in preparation of media or bacterial inoculums. The inoculated plate
was incubated at 35 °C for 24 h. The lowest concentration of plant
fraction that inhibited visible bacterial growth was considered the MIC.
Each plant fraction was examined twice in each run [31,32].
2.7.2. Determination of anti-yeast activity of plant fractions
The MIC of the studies plant fractions against Candida albicans was
determined by broth microdilution similar to [33,34]. In this proce-
dure, RPMI1640 was used instead of MHB.
2.7.3. RPMI1640 preparation
A weight of 1.04 g of RPMI powder was dissolved in 90 ml sterile,
distilled water. MOP (3.456 g) was added to the solution. The pH of the
solution was adjusted to 7 at 25 °C by using 1 mol/l NaOH. Then, sterile
distilled water was added up to 100 ml. The solution was sterilized by
ﬁltration through 0.45 μm syringe ﬁlter.
2.7.4. Broth microdilution
A volume of 100 μl of RPMI 1640 broth media was placed in each
well. Then, 100 μl of plant fraction was placed in ﬁrst well and mixed.
This was followed by 100 μl from the ﬁrst well to the second one. This
step was repeated up to wells number 11 from which 100 μlwas dis-
charged after mixing. Well number 12 contained only RPMI 1640 broth
and represents the positive control of yeast growth. The concentrations
of plant fraction in the micro-wells were assigned to evaluate their
antifungal activities ranged from 0.065 to 55 mg/ml.
2.7.5. Inoculum preparation
Candida albicans was sub-cultured on sabouraud dextrose agar at
37 °C for 24 h. Five colonies were placed in 5 ml 8.5% saline. Then, cell
density was adjusted to 0.5 McFarland’s standard (0.08 to 0.1 absor-
bance at 625 nm) to obtain a yeast concentration 1 × 106 to
5 × 106 CFU/ml. This suspension was of Candida albicans, was diluted
1:50 and then 1:20 with broth medium (RPMI 1640 broth), which re-
sults in 1 × 103 to 5 × 103 CFU/ml, from which 100 μl was pippeted
into each well except well number 11, which represented negative
control of yeast growth. All of the inoculated plates were incubated at
35 °C. The incubation period was 48 h. The ﬁnal concentrations of
microbial cells were about 0.5–2.5 × 103 colony-forming unit (CFU)/
ml.
2.7.6. Determination of anti-mould activity
Epidermatophyton ﬂoccosum mould inhibition by plant fraction was
evaluated by agar dilution method [34,35]. Sabouraud dextrose agar
(SDA) was placed in tubes and kept at 40 °C water bath after ster-
ilization by autoclave. Plant fractions were serially diluted with SDA.
The prepared concentrations were from 0.78 to 25 mg/ml for aqueous
fractions and organic fractions. Then, the prepared tubes were allowed
to solidify in slanted position at room temperature. A suspension with
turbidity similar to 0.5 McFarland standard which was prepared from a
fresh culture of Epidermatophyton ﬂoccosum. Then 20 μl of the suspen-
sion of was added to all tubes. Tubes with SDA only were used as
positive control of the mould. Results were taken after 10 days of in-
cubation at 25 °C. Minimum inhibitory concentration was the lowest
concentration that completely inhibits the growth of Epidermatophyton
ﬂoccosum.
2.8. Antioxidant DPPH method
A stock solution of a concentration of 1 mg/ml in methanol was
ﬁrstly prepared for the plant fractions and Trolox. The working solu-
tions of the following concentrations (1, 2, 3, 5, 7, 10, 20, 30, 40, 50,
80, 100 μg/ml) were prepared by serial dilution with methanol from
the stock solution. DPPH was freshly prepared at a concentration of
0.002% w/v. The DPPH solution was mixed with methanol and the
above-prepared working concentration in a ratio of 1:1:1 respectively.
The spectrophotometer was zeroed using methanol as a blank solution.
The ﬁrst solution of the series concentration was DPPH with methanol
only. The solutions were incubated in dark for 30 min at room tem-
perature before the absorbance readings were recorded at 517 nm. The
percentage of antioxidant activity of the plants and the Trolox standard
were calculated using the following formula:
Inhibition of DPPH activity (%) = (B− S)/B × 100%
Where:
B= optical density of the blank,
S= optical density of the sample.
The antioxidant half maximal inhibitory concentration (IC50) for the
plant samples and the standard were calculated using BioDataFit edi-
tion 1.02 (data ﬁt for biologist). Determination of antioxidant activity
was carried out in triplicate for each sample. The obtained results were
presented as means ± standard deviation (SD) and then were com-
pared using an unpaired t-test.
3. Results
The yields of the fractionation for aqueous, acetone, methanol and
n-hexane solvents which were conducted under the same working
conditions were assessed (Table 1) and phytochemical markers detec-
tion in each collected fraction was performed (Table 2) during the se-
paration process.
The highest extraction yield for O. pubescens was obtained using
methanol (23%) and the qualitative phytochemical screening results
revealed that cardiac glycosides were found in the aqueous, acetone
and n-hexane fractions, while phenols were identiﬁed in methanol and
acetone fractions, as well as tannin, were found in the acetone and
aqueous fractions. In addition, steroids were identiﬁed in the aqueous,
acetone and n-hexane fractions, while terpenoids were found in all
fractions except methanol fraction. Meanwhile, ﬂavonoid was identi-
ﬁed in the methanol and acetone fractions and carbohydrates were
found in all the studied plant fractions. The most eﬀective fraction was
acetone fraction as its rich in several bioactive phytochemical classes
3.1. Antimicrobial activity
The organic fractions of O. pubescens exhibited antimicrobial
bioactivity against the growth of the majority of screened pathogens
included in this study. While, the aqueous O. pubescens fraction did not
Table 1
Fractionations yields of O. pubescens aqueous, acetone, methanol and hexane solvents.
Fractions Dried plant weight (g) Plant fractions (g) Yields, %
Hexane 25 g 2.12 g 8.48%
Acetone 25 g 4.15 g 16.6%
Methanol 25 g 5.75 g 23%
Aqueous 25 g 1.73 g 6.92%
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exhibit any antibacterial or antifungal bioactivity as presented in
Table 3.
3.2. Antioxidant properties
DPPH free radical scavenging assay was adopted for evaluation of
antioxidant power for each prepared aqueous, acetone, n-hexane, and
methanol O. pubescens fractions. Trolox was used as a reference stan-
dard compound in various concentrations, which were ranged from 1 to
100 μg/ml. The zero inhibition concentration was considered for the
DPPH and methanol without any plant fraction.
Fig. 1 shows the inhibition of DPPH for each O. pubescens fraction
that used to make a comparative in-vitro evaluation of antioxidant
activities.
The results revealed that an excellent antioxidant activity, with IC50
8.67 μg/ml, was exhibited by O. pubescens acetone fraction, followed by
O. pubescens aqueous fraction with IC50 15.14 μg/ml and followed by O.
pubescens methanol fraction with IC50 19.41 μg/ml, while the n-hexane
fraction was the least antioxidant fraction with IC50 34.67 μg/ml. All
these results were comparable to a Trolox standard that has IC50
2.11 μg/ml. The detailed results are shown in Table 4 with their percent
of inhibition according to Trolox.
4. Discussion
Due to its geographical position, Palestine has interesting potential
in the ﬁeld of medicinal plants and is classiﬁed as one of the most
botanically rich countries in the Mediterranean region. In fact, the
Palestinian ﬂora is diverse with about 27500 species and subspecies, of
which about 300 plants are currently used in folk medicine. This eco-
logical diversity is the natural reservoir of bioactive molecules, which is
of great interest to the cosmetic, food and pharmaceutical industries
[36,37].
The majority of recent medicines that have been discovered from
plants or other natural products and have been investigated due to
human experience and subsequently clinical trials. Accordingly, for the
treatment of speciﬁc diseases, the pharmacologically active compounds
have been isolated and analyzed its entity to produce speciﬁc medica-
tions like penicillin, morphine, pilocarpine and many others [38,39].
In the 20 century, the advanced chemical analytical techniques have
emerged to facilitate isolation of the natural active ingredients. In ad-
dition, the evolution of drugs receptor theory which suggests a mole-
cular interaction of unique chemical structure compounds to body
macromolecules like proteins and nucleic acid which resulting in dis-
covering the required therapeutic agents [40–42].
Recently, investigations of new sources of natural antioxidant
agents have been attracting an increasing attention because these
compounds are inexpensive and safe since some chemical synthetic
antioxidants showed health risk and toxicity [43–46].
The present study evaluated the antioxidant activity of O. pubescens
four fractions with a wide range of polarity by using free radical
scavenging DPPH method. In summary, O. pubescens acetone fraction
showed an excellent antioxidant activity, with IC50 8.67 μg/ml, fol-
lowed by O. pubescens aqueous fraction with IC50 15.14 μg/ml and
followed by O. pubescens methanol fraction with IC50 19.41 μg/ml,
while the n-hexane fraction was the least antioxidant fraction with IC50
34.67 μg/ml. All these results were comparable to Trolox standard that
has IC50 2.11 μg/ml.
In a study which was conducted by El Guiche et al. in Morocco
which evaluated the antioxidant activity by using DPPH method in
Ononis natrix plant, found that the methanol fraction has 90.12 μg/ml
[47]. Moreover, in another study which was conducted by Valyova
et al. found that the antioxidant activity of methanol extract of Ononis
spinosa by using the same method was 59.1 μg/ml [48]. Therefore, our
Table 2
Phytochemical screening tests for the aqueous, methanol, acetone and n-hexane fractions
of O. pubescens.
Phytochemical
Compounds
Aqueous
fraction
Methanol
fraction
Acetone
fraction
n-Hexane
fraction
Cardiac glycosides + – + +
Saponin glycoside – – – –
Alkaloids – – – –
Protein – – – –
Starch – – – –
Phenols – + + –
Carbohydrates + + + +
Tannin + – + –
Steroids + – + +
Reducing sugar – – – –
Monosaccharide – – – –
Terpenoids + – + +
Flavonoid – + + –
Table 3
Antimicrobial activities (MICs) of O. pubescens methanol, aqueous, n-hexane and acetone
fractions.
Microorganisms MIC, mg/ml
acetone
fraction
MIC, mg/ml
n-hexane
fraction
MIC, mg/ml
methanol
fraction
MIC, mg/
ml aqueous
fraction
Staphylococcus
aureus
12.5 mg/ml 1.563 mg/ml 25 mg/ml NI
MRSA 25 mg/ml 6.25 mg/ml 6.25 mg/ml NI
Shigella sonnie 12.5 mg/ml NI 25 mg/ml NI
Entrococuss feacium 6.25 mg/ml 12.25 mg/ml 12.5 mg/ml NI
Escherichia coli 12.5 mg/ml 25 mg/ml 25 mg/ml NI
Pseudomonas
arginosa (ATCC
27853)
12.5 mg/ml 12.5 mg/ml 6.25 mg/ml NI
Candida albicans NI 12.5 mg/ml 12.5 mg/ml NI
Epidermatophyto
ﬂacosum (ATCC
10231)
3.125 mg/ml 3.125 mg/ml 3.125 mg/ml NI
NI: No Inhibition.
Fig. 1. Inhibition activity of Trolox reference standard compound and four O. pubescens
fractions.
Table 4
DPPH free radical scavenging activity (IC50) and inhibition percentages according to
Trolox of n-hexane, acetone, methanol, and aqueous fractions of O. pubescens.
Inhibition, % according to Trolox IC50 (μg/ml) Fraction type
6.09 34.67 ± 0.97** n-hexane
24.37 8.67 ± 0.77** Acetone
10.88 19.41 ± 1.1*** Methanol
13.96 15.14 ± 1.09** Aqueous
100 2.11 ± 0.88*** Trolox
Where: ** indicate a p value of≤ 0.001 and *** indicate a p value of≤ 0.0001.
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studied species have higher antioxidant potential than previously con-
ducted studies on other Ononis species.
Throughout the history of humanity, bacterial infections and their
related diseases have killed many people around the world. Therefore,
during the 20th century with the discovery of antibiotics such as pe-
nicillin and others hallmarked the beginning of the antibiotic era,
which has saved the lives of people around the globe [49].
On the other hand, worldwide misusage of antibiotics has caused
the emergence and spread of antibiotic-resistant strains of bacterial
pathogens. The emergence of highly resistant strains of bacterial pa-
thogens such as VRSA and MRSA, Gram-negative bacteria that are re-
sistant to Carbapenems and ESBL, antibiotic resistant tuberculosis,
draws the attention of scientists to the threat that is imposed by the
spread of antibiotic-resistant bacteria strains. Therefore, micro-
biologists and pharmacologists are seriously concerned about the pos-
sibility of going back to the pre-antibiotic era as more and more anti-
biotics are becoming useless in treating infections caused by such
strains [50,51].
This serious concern about going back to the pre-antibiotic era has
triggered massive investigations that aim to discover new drugs as al-
ternatives to antibiotics for treatment of bacterial infections. Most of
these investigations have been focusing on folkloric plants which used
to treat bacterial infections [52,53] and for many decades enormous
investigations have shown that phytogenic products produced various
chemicals with antibacterial and antifungal properties [54,55].
Interestingly, in the Palestinian ethnomedicine, numerous plants
have been used for the treatment of infectious diseases, O. pubescens
being one these plants which has been reported in the folk medicine for
treatment of upper respiratory system infections [27].
Antibacterial tests were conducted against six ATCCs and clinical
isolates bacterial stains while antifungal tests were established against
two fungal pathogens. Table 3 showed that the higher inhibition ac-
tivity (the lowest MIC) of the acetone fraction was against Entrococuss
feacium bacteria and against Epidermatophyto ﬂacosum fungi with MICs
6.25 mg/ml and 3.125 mg/ml, respectively, furthermore the n-hexane
fraction showed the highest inhibition activity against Staphylococcus
aureus with MIC 1.563 mg/ml and the best antifungal inhibition activity
was against Epidermatophyto ﬂacosum with MIC 3.125 mg/ml. In addi-
tion, the best antibacterial activity of the methanol fraction was against
Pseudomonas arginosa and MRSA with MIC6.25 mg/ml for both of them,
while it has the best antifungal activity was against Epidermatophyto
ﬂacosum with MIC 3.125 mg/ml. But unfortunately, the aqueous frac-
tion was inactive against all the studied bacterial and fungal strains.
That means that the best activity against Staphylococcus aureus
strain was O. pubescens n-hexane fraction with MIC 1.563 mg/ml, and
the best activity against MRSA were O. pubescens n-hexane and me-
thanol fractions with MIC 6.25 mg/ml for both fractions. Furthermore,
the best activity against Shigella sonnie was reached with O. pubescens
acetone fraction with MIC 12.5 mg/ml. While, the best antibacterial
property against Entrococuss feacium was achieved by O. pubescens
acetone fraction with MIC 6.25 mg/ml. The best antibacterial activity
against Escherichia coli was also O. pubescens acetone fraction with MIC
12.5 mg/ml. While, the best antibacterial bioactivity against
Pseudomonas aeruginosa was O. pubescens methanol fraction with MIC
6.25 mg/ml.
Our results showed that the antifungal bioactivity of the acetone, n-
hexane and the methanol O. pubescens fractions were noticeably high
against Epidermatophyto ﬂacosum with MIC 3.125 mg/ml for all these
fractions. Meanwhile, the aqueous fraction did not show any bioactivity
against this fungus. Moreover, the n-hexane and methanol O. pubescens
fractions showed antifungal bioactivity against Candida albicans with
MIC 12.5 mg/ml, while the aqueous and acetone O. pubescens fractions
were inactive against this pathogen.
The separation of active compounds of O. pubescens plant has not
been attempted in this study as separation with column chromato-
graphy requires huge amounts of the plant which was not available at
this time. In addition, isolation, chemical structure elucidation, and
determination of structure activity relationship (SAR) of the most
therapeutic active compounds from O. pubescens fractions are limita-
tions in this study. However, these experiments will be our future goal.
5. Conclusion
The studied plant four fractions revealed a potential interest in their
antioxidant activities, and the majority of the studied organic fractions
inhibited relevant microbial strains thereby validating its folk use in the
treatment of upper respiratory system infections. Further phytochem-
ical investigations directed at isolation and structural identiﬁcation are
recommended, which may lead to new antimicrobial compounds and in
vivo studies that may validate the in vitro ﬁndings.
Authors contribution
All research done by the authors.
Conﬂict of interest statement
The authors declare that there are no conﬂicts of interest.
Financial support
None.
Ethical approval
N/A.
Acknowledgements
The authors wish to thank An-Najah National University for its
support to carry out this work and many thanks to the technicians
Mohamad Arar and Linda Esa.
References
[1] S. Hosseinzadeh, A. Jafarikukhdan, A. Hosseini, R. Armand, The application of
medicinal plants in traditional and modern medicine: a review of Thymus vulgaris,
Int. J. Clin. Med. 6 (09) (2015) 635–641.
[2] D.G. Kingston, Modern natural products drug discovery and its relevance to bio-
diversity conservation, J. Nat. Prod. 74 (3) (2011) 496–501.
[3] M.J. Balunas, A.D. Kinghorn, Drug discovery from medicinal plants, Life Sci. 78 (5)
(2005) 431–441.
[4] A. Bernhoft, H. Siem, E. Bjertness, M. Meltzer, T. Flaten, E. Holmsen, Bioactive
Compounds in Plants–Beneﬁts and Risks for Man and Animals, The Norwegian
Academy of Science and Letters, Oslo, 2010.
[5] W.H. Talib, A.M. Mahasneh, Antimicrobial, cytotoxicity and phytochemical
screening of Jordanian plants used in traditional medicine, Molecules 15 (3) (2010)
1811–1824.
[6] L. Tan, H. Ser, W. Yin, K. Chan, L. Lee, B. Goh, Investigation of antioxidative and
anticancer potential of Streptomyces sp, Actinobacteria in Special and Extreme
Habitats: diversity, Funct. Roles Environ. Adapt. 6 (2016) 181–187.
[7] G.M. Cragg, D.J. Newman, Natural products: a continuing source of novel drug
leads, Biochim. Biophy. Acta (BBA)-Gen. Subj. 1830 (6) (2013) 3670–3695.
[8] C.-F. Kuok, S.-O. Hoi, C.-F. Hoi, C.-H. Chan, I.-H. Fong, C.-K. Ngok, L.-R. Meng,
P. Fong, Synergistic antibacterial eﬀects of herbal extracts and antibiotics on me-
thicillin-resistant staphylococcus aureus: a computational and experimental study,
Exp. Biol. Med. 242 (7) (2017) 731–743 (1535370216689828).
[9] R. Laxminarayan, A. Duse, C. Wattal, A.K. Zaidi, H.F. Wertheim, N. Sumpradit,
E. Vlieghe, G.L. Hara, I.M. Gould, H. Goossens, Antibiotic resistance—the need for
global solutions, Lancet Infect. Dis. 13 (12) (2013) 1057–1098.
[10] G. Sussman, Antimicrobial resistance relating to wound management and infection,
Wound Pract. Res.: J. Aust. Wound Manage. Assoc. 24 (4) (2016) 224–231.
[11] M.R. Shurin, J. Zong, A.A. Keskinov, Infection and Cancer: Multi-directorial
Relationship, Infection and Cancer: Bi-Directorial Interactions, Springer, USA,
2015, pp. 1–10.
[12] T. Ishrat, M.N. Hoda, M.B. Khan, S. Yousuf, M. Ahmad, M.M. Khan, A. Ahmad,
F. Islam, Amelioration of cognitive deﬁcits and neurodegeneration by curcumin in
rat model of sporadic dementia of Alzheimer's type (SDAT), Eur. Neuropsychoph.
19 (9) (2009) 636–647.
[13] M. Asori, A. Hedayatizadeh-Omran, Antioxidant activity and free radical
N.A. Jaradat et al. European Journal of Integrative Medicine 14 (2017) 46–51
50
scavenging properties of captopril, Asian J. Chem. 23 (8) (2011) 3713–3719.
[14] S. Fulda, Modulation of apoptosis by natural products for cancer therapy, Planta
Med. 76 (11) (2010) 1075–1079.
[15] R.E. Marhuenda, G.M. Garcia, C.M. Martin, S.M. Remesal, The antihypertensive
activity of Ononis natrix L, Farmaco Prat 42 (2) (1987) 45–49.
[16] M.A. Al-Qudah, A.M. Al-Ghoul, I.N. Trawenh, H.I. Al-Jaber, T.M. Al Shboul,
M.H. Abu Zarga, S.T. Abu orabi, Antioxidant activity and chemical composition of
essential oils from Jordanian Ononis natrix L. and Ononis sicula Guss, J. Biol. Active
Prod. Nat. 4 (1) (2014) 52–61.
[17] B. Mhamdi, F. Abbassi, C. Abdelly, Chemical composition, antioxidant and anti-
microbial activities of the edible medicinal Ononis natrix growing wild in Tunisia,
Nat. Prod. Res. 29 (12) (2015) 1157–1160.
[18] E.M. Altuner, T. Ceter, C. İşlek, Investigation of antifungal activity of Ononis spi-
nosa L. ash used for the therapy of skin infections as folk remedies, Mikrobiyol. Bul.
44 (4) (2010) 633–639.
[19] B.S. Yõlmaz, H. Özbek, G.S. Çitoğlu, S. Uğraş, İ. Bayram, E. Erdoğan, Analgesic and
hepatotoxic eﬀects of Ononis spinosa L, Phytother. Res. 20 (6) (2006) 500–503.
[20] W.H. Talib, A.M. Mahasneh, Antiproliferative activity of plant extracts used against
cancer in traditional medicine, Sci. Pharm. 78 (1) (2010) 33–46.
[21] N. Feinbrun-Dothan, Flora Palaestina, Academy of Sciences and Humanities,
Jerusalem, 1986.
[22] I. Albaba, A list of important honeybee nectariferous and polleniferous plant species
in the west bank governorates, Palestine, J. Agr. Sci. Tech. A 5 (2015) 114–121.
[23] A.F. Barrero, E. Cabrera, I. Rodríguez, F. Planelles, Alkylresorcinols and iso-
coumarins from Ononis pubescens, Phytochemistry 35 (2) (1994) 493–498.
[24] N. Tsuge, M. Mizokami, S. Imai, A. Shimazu, H. Seto, Adipostatins A and B, new
inhibitors of glycerol-3-phosphate dehydrogenase, J. Antibiot. 45 (6) (1992)
886–891.
[25] R.T. Scannell, J.R. Barr, V. Murty, K.S. Reddy, S.M. Hecht, DNA strand scission by
naturally occurring 5-alkylresorcinols, J. Am. Chem. Soc. 110 (11) (1988)
3650–3651.
[26] W.J. Hooker, The British Flora: Comprising the Phaenogamous, or Flowering Plants,
and the Ferns, Longman, Rees, Orme, Brown &Green, UK, 1830.
[27] M. Ali-Shtayeh, R.M. Jamous, Traditional Arabic Palestinian Herbal Medicine,
Biodiversity and Environmental Research Center, Palestine, 2008.
[28] C. Michel, M. El-sherei, W. Islam, A. Sleem, S. Ahmed, Bioactivity-guided fractio-
nation of the stem bark extract of Pterocarpus dalbergioides Roxb. ex Dc growing in
Egypt, Bull. Fac. Pharm. 51 (1) (2013) 1–5 (Cairo University).
[29] G. Trease, W. Evans, Pharmacognosy, 12th ed., Bailliere Tindall, London, 1983.
[30] J.B. Harborne, Phytochemical Methods a Guide to Modern Techniques of Plant
Analysis, Springer Science & Business Media, Germany, 1998.
[31] B.A. Forbes, D.F. Sahm, A.S. Weissfeld, Study Guide for Bailey & Scott's Diagnostic
Microbiology, Mosby, USA, 2007.
[32] M.A. Wikler, Performance Standards for Antimicrobial Susceptibility Testing:
Seventeenth Informational Supplement, Clinical and Laboratory Standards
Institute, USA, 2007.
[33] M.E. Klepser, E.J. Wolfe, R.N. Jones, C.H. Nightingale, M.A. Pfaller, Antifungal
pharmacodynamic characteristics of ﬂuconazole and amphotericin B tested against
Candida albicans, Antimicrob. Agents Chemother. 41 (6) (1997) 1392–1395.
[34] B.A. Forbes, D.F. Sahm, A.S. Weissfeld, Study Guide for Bailey and Scott's
Diagnostic Microbiology, Elsevier Health Sciences, 2016.
[35] M. Falahati, N.O. Tabrizib, F. Jahaniani, Anti dermatophyte activities of Eucalyptus
camaldulensis in comparison with Griseofulvin, Iranian J. Pharmacol. Ther. 4 (2)
(2005) 80–83.
[36] N.A. Jaradat, R. Shawahna, A.M. Eid, R. Al-Ramahi, M.K. Asma, A.N. Zaid, Herbal
remedies use by breast cancer patients in the West Bank of Palestine, J.
Ethnopharmacol. 178 (2016) 1–8.
[37] N.A. Jaradat, R. Al-Ramahi, A.N. Zaid, O.I. Ayesh, A.M. Eid, Ethnopharmacological
survey of herbal remedies used for treatment of various types of cancer and their
methods of preparations in the West Bank-Palestine, BMC Complement. Altern.
Med. 16 (1) (2016) 93–105.
[38] K. Anil, Ethnomedicine: a Source of Complementary Therapeutics, Debprasad
Chattopadhyay, India, 2010.
[39] C.G. Wermuth, Strategies in the search for new lead compounds or original working
hypotheses, Pract. Medchem. 3 (2003) 126–129.
[40] S. Ekins, J. Mestres, B. Testa, In silico pharmacology for drug discovery: methods for
virtual ligand screening and proﬁling, Br. J. Pharmacol. 152 (1) (2007) 9–20.
[41] S.P. Leelananda, S. Lindert, Computational methods in drug discovery, Beilstein J.
Org. Chem. 12 (2016) 2694–2718.
[42] M. Lahlou, The success of natural products in drug discovery, Pharmacol. Pharm. 4
(2013) 17–31.
[43] A. Mezrag, N. Malafronte, M. Bouheroum, C. Travaglino, D. Russo, L. Milella,
L. Severino, N. De Tommasi, A. Braca, F. Dal Piaz, Phytochemical and antioxidant
activity studies on Ononis angustissima L. aerial parts: isolation of two new ﬂavo-
noids, Nat. Prod. Res. 31 (5) (2017) 507–514.
[44] E. Fernández, I. Viehmannová, J. Lachman, L. Milella, Yacon [Smallanthus sonchi-
folius(Poepping & endlicher) H. robinson]: a new crop in the central europe, Plant
Soil Environ. 52 (12) (2006) 564–570.
[45] J. Alam, F. Subhan, I. Ullah, M. Shahid, G. Ali, R.D. Sewell, Synthetic and natural
antioxidants attenuate cisplatin-induced vomiting, BMC Pharmacol. Toxicol. 18 (1)
(2017) 4.
[46] L. Packer, Handbook of Synthetic Antioxidants, CRC Press, USA, 1997.
[47] R. El Guiche, S. Tahrouch, O. Amri, K. El Mehrach, A. Hatimie, Antioxidant activity
and total phenolic and ﬂavonoid contents of 30 medicinal and aromatic plants lo-
cated in the South of Morocco, Int. J. New Technol. Res. 1 (2015) 7–11.
[48] M. Valyova, V. Hadjimitova, S. Stoyanov, Y. Ganeva, T. Traykov, I. Petkov, Radical
scavenger and antioxidant activities of extracts and fractions from Bulgarian Ononis
spinosa L. and GC–MS analysis of ethanol extract, Internet J. Altern. Med. 7 (2)
(2009) 1–5.
[49] N. Woodford, D.M. Livermore, Infections caused by Gram-positive bacteria: a re-
view of the global challenge, J. Infect. 59 (2009) 4–16.
[50] S.B. Levy, B. Marshall, Antibacterial resistance worldwide: causes, challenges and
responses, Nat. Med. 10 (2004) S122–S129.
[51] C.L. Ventola, The antibiotic resistance crisis: part 1: causes and threats, Pharmacol.
Ther. 40 (4) (2015) 277–283.
[52] C. Walsh, Where will new antibiotics come from? Nat. Rev. Microbiol. 1 (1) (2003)
65–70.
[53] J. Rios, M. Recio, Medicinal plants and antimicrobial activity, J. Ethnopharmacol.
100 (1) (2005) 80–84.
[54] K. Bacha, Y. Tariku, F. Gebreyesus, S. Zerihun, A. Mohammed, N. Weiland-Bräuer,
R.A. Schmitz, M. Mulat, Antimicrobial and anti-quorum sensing activities of se-
lected medicinal plants of Ethiopia: implication for development of potent anti-
microbial agents, BMC Microbiol. 16 (1) (2016) 139.
[55] A.C. Abreu, A.J. McBain, M. Simoes, Plants as sources of new antimicrobials and
resistance-modifying agents, Nat. Prod. Rep. 29 (9) (2012) 1007–1021.
N.A. Jaradat et al. European Journal of Integrative Medicine 14 (2017) 46–51
51
